 WESTPORT, Conn., Sept. 10, 2021 GLOBE NEWSWIRE -- Portage Biotech Inc. NASDAQ: PRTG Portage or the Company, a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that as part of its commitment to investor outreach, management will be participating in the following investor conferences in September 2021. 